Intramuscular PDX Models Show High Engraftment for Gastric Cancer Drug Testing
An optimized intramuscular patient-derived xenograft (PDX) platform demonstrates high engraftment rates in gastric cancer, enhancing individualized drug testing and biomarker discovery.